Amplyx Pharmaceuticals Company
Amplyx focuses on developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems
Industry:
PharmTech
Technology:
Metabolic Disorders
Funding Status:
M&A
Estimated Revenue:
$10M to $50M
Headquarters:
San Diego, California, United States
Employee Number:
11-50
Founded Date:
2006